Aimwell Partners Launches Program to Verify Physician Profiles for AI Accuracy
News related to:Aimwell Partners Inc · 2 min read
MIAMI, October 1, 2026 /CourierPR/ -- Aimwell Partners Inc., the parent company of AimwellBio, has launched a new program aimed at ensuring verified professional profiles for physicians and doctors of chiropractic. The initiative seeks to address the growing reliance of patients on artificial intelligence (AI) for health information and provider selection.
According to John Morgan, CEO of Aimwell Partners Inc., the program is essential as patients increasingly turn to AI for health-related inquiries.
The program, which is open to physicians across specialties and now includes doctors of chiropractic, offers several key features. It includes verified professional profiles, structured and AI-indexable, that document each physician's identity, credentials, areas of focus, and practice information. These profiles are built on AimwellBio's Observer verification layer, ensuring accuracy and reliability.
Additionally, the program provides nationwide press opportunities for participating professionals. These features are designed to provide accessible, citable information about the participating physicians and their work, subject to publisher standards. AimwellBio also offers complimentary visibility assessments, which are plain-language reviews of how a practice appears across selected AI and search platforms. These assessments identify missing, outdated, or inaccurate information, helping practices to improve their online presence.
The program is part of AimwellBio's broader healthcare intelligence ecosystem, including Observer network membership, verified professional profiles, and access to AIMN:ATLAS, the company's public global intelligence map.
The program also connects participating professionals with the Founding Physician network, which was announced on September 15, 2026. This network is subject to its separate selection criteria and availability.
Aimwell Partners Inc. is headquartered in Miami, Florida, and operates as a verified intelligence platform serving healthcare and biopharma. The company's platform combines AIMWELL Cortex adversarial validation, the public AIMN:ATLAS intelligence map, the Observer credentialed professional network, and the FHIN contributor framework.
The launch of this program is part of Aimwell Partners Inc.'s ongoing efforts to ensure that accurate and up-to-date information about healthcare professionals is available to patients seeking care. By addressing the gaps in AI-generated descriptions, the company aims to provide clearer and more reliable information for both patients and healthcare providers.